@article{51720abf6caf4adc96be71431d2dd343,
title = "Evaluating health technology through pragmatic trials novel approaches to generate high-Quality evidence",
author = "Peterson, {Eric D.} and Harrington, {Robert A.}",
note = "Funding Information: have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Peterson reported receiving grants from Verily Inc, Akili, and Reflexion Health and personal fees from Livogo. He directs the Duke Clinical Research Institute, which runs many pragmatic clinical trials. Dr Harrington reported receiving grants from Apple, Sanofi, AstraZeneca, Portola, Janssen, Bristol-Myers Squibb, Novartis, CSL, and The Medicines Company and personal fees from Bayer; serving on consulting/advisory boards of Amgen, Element Science, Gilead, MyoKardia, and WebMd; and serving on the board of directors of Signal Path, Scanadu, American Heart Association, and Stanford Health Care.",
year = "2018",
month = jul,
day = "10",
doi = "10.1001/jama.2018.8512",
language = "English (US)",
volume = "320",
pages = "137--138",
journal = "JAMA - Journal of the American Medical Association",
issn = "0098-7484",
publisher = "American Medical Association",
number = "2",
}